Wenzhou Kangning Hospital Co., Ltd. (2120.HK)
HKD 9.78
(2.73%)
HKD 9.78
(2.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 639.3 Million CNY | 17.66% |
| 2022 | 543.36 Million CNY | -13.23% |
| 2021 | 626.23 Million CNY | 39.79% |
| 2020 | 447.97 Million CNY | 27.33% |
| 2019 | 351.82 Million CNY | 700.99% |
| 2018 | 43.92 Million CNY | 159.89% |
| 2017 | -73.33 Million CNY | 60.04% |
| 2016 | -183.51 Million CNY | 42.37% |
| 2015 | -318.45 Million CNY | -754.44% |
| 2014 | -37.27 Million CNY | 44.5% |
| 2013 | -67.16 Million CNY | -241.97% |
| 2012 | -19.63 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | 639.3 Million CNY | -4.65% |
| 2023 Q1 | 663.9 Million CNY | 22.18% |
| 2023 FY | 639.3 Million CNY | 17.66% |
| 2023 Q3 | 670.47 Million CNY | 1.14% |
| 2023 Q2 | 662.89 Million CNY | -0.15% |
| 2022 Q2 | 733.04 Million CNY | -2.14% |
| 2022 FY | 543.36 Million CNY | -13.23% |
| 2022 Q4 | 543.36 Million CNY | -2.84% |
| 2022 Q3 | 559.22 Million CNY | -23.71% |
| 2022 Q1 | 749.04 Million CNY | 19.61% |
| 2021 Q2 | 539.9 Million CNY | 9.11% |
| 2021 Q4 | 626.23 Million CNY | 5.04% |
| 2021 Q3 | 596.19 Million CNY | 10.43% |
| 2021 FY | 626.23 Million CNY | 39.79% |
| 2021 Q1 | 494.83 Million CNY | 10.46% |
| 2020 Q2 | 468.1 Million CNY | 4.92% |
| 2020 FY | 447.97 Million CNY | 27.33% |
| 2020 Q4 | 447.97 Million CNY | 8.05% |
| 2020 Q3 | 414.59 Million CNY | -11.43% |
| 2020 Q1 | 446.14 Million CNY | 26.81% |
| 2019 Q4 | 351.82 Million CNY | 7.26% |
| 2019 Q3 | 328.01 Million CNY | -14.75% |
| 2019 Q2 | 384.74 Million CNY | 9.41% |
| 2019 Q1 | 351.64 Million CNY | 700.6% |
| 2019 FY | 351.82 Million CNY | 700.99% |
| 2018 Q4 | 43.92 Million CNY | 0.0% |
| 2018 Q3 | 43.92 Million CNY | 273.96% |
| 2018 Q2 | 11.74 Million CNY | 0.0% |
| 2018 Q1 | 11.74 Million CNY | 116.02% |
| 2018 FY | 43.92 Million CNY | 159.89% |
| 2017 Q4 | -73.33 Million CNY | 0.0% |
| 2017 Q2 | -84.48 Million CNY | 0.0% |
| 2017 Q1 | -84.48 Million CNY | 53.96% |
| 2017 Q3 | -73.33 Million CNY | 13.2% |
| 2017 FY | -73.33 Million CNY | 60.04% |
| 2016 FY | -183.51 Million CNY | 42.37% |
| 2016 Q2 | -202.36 Million CNY | 0.0% |
| 2016 Q4 | -183.51 Million CNY | 32.77% |
| 2016 Q3 | -272.96 Million CNY | -34.88% |
| 2016 Q1 | -202.36 Million CNY | 36.45% |
| 2015 Q2 | -39.82 Million CNY | 0.0% |
| 2015 FY | -318.45 Million CNY | -754.44% |
| 2015 Q4 | -318.45 Million CNY | 0.0% |
| 2015 Q3 | -318.45 Million CNY | -699.66% |
| 2015 Q1 | -39.82 Million CNY | -6.85% |
| 2014 Q4 | -37.27 Million CNY | 0.0% |
| 2014 FY | -37.27 Million CNY | 44.5% |
| 2014 Q3 | -37.27 Million CNY | 0.0% |
| 2013 FY | -67.16 Million CNY | -241.97% |
| 2012 FY | -19.63 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aidigong Maternal & Child Health Limited | 767.09 Million HKD | 16.658% |
| UMP Healthcare Holdings Limited | -201.47 Million HKD | 417.314% |
| Human Health Holdings Limited | -458.04 Million HKD | 239.574% |
| EuroEyes International Eye Clinic Limited | -336.12 Million HKD | 290.201% |
| Kato (Hong Kong) Holdings Limited | 336.39 Million HKD | -90.048% |
| Bamboos Health Care Holdings Limited | -18.02 Million HKD | 3646.193% |
| Beijing Health (Holdings) Limited | -106.46 Million HKD | 700.475% |
| C-MER Eye Care Holdings Limited | -149.77 Million HKD | 526.854% |
| Town Health International Medical Group Limited | -738.7 Million HKD | 186.544% |
| Medicskin Holdings Limited | -15.06 Million HKD | 4344.507% |
| Hang Chi Holdings Limited | 32.96 Million HKD | -1839.412% |